Global Pazopanib Market Growth 2025-2031

December 2025 | 84 pages | ID: G0C646E7C37EN
LP Information

Abstracts

The global Pazopanib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Pazopanib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pazopanib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pazopanib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pazopanib players cover Novartis, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pazopanib Industry Forecast” looks at past sales and reviews total world Pazopanib sales in 2024, providing a comprehensive analysis by region and market sector of projected Pazopanib sales for 2025 through 2031. With Pazopanib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pazopanib industry.

This Insight Report provides a comprehensive analysis of the global Pazopanib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pazopanib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pazopanib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pazopanib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pazopanib.

This report presents a comprehensive overview, market shares, and growth opportunities of Pazopanib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 200mg Tables
• 400mg Tables

Segmentation by Application:

• Renal Cell Carcinoma
• Soft Tissue Sarcoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis
• GlaxoSmithKline

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pazopanib market?

What factors are driving Pazopanib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pazopanib market opportunities vary by end market size?

How does Pazopanib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pazopanib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Pazopanib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Pazopanib by Country/Region, 2020, 2024 & 2031
2.2 Pazopanib Segment by Type
  2.2.1 200mg Tables
  2.2.2 400mg Tables
2.3 Pazopanib Sales by Type
  2.3.1 Global Pazopanib Sales Market Share by Type (2020-2025)
  2.3.2 Global Pazopanib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Pazopanib Sale Price by Type (2020-2025)
2.4 Pazopanib Segment by Application
  2.4.1 Renal Cell Carcinoma
  2.4.2 Soft Tissue Sarcoma
  2.4.3 Others
2.5 Pazopanib Sales by Application
  2.5.1 Global Pazopanib Sale Market Share by Application (2020-2025)
  2.5.2 Global Pazopanib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Pazopanib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Pazopanib Breakdown Data by Company
  3.1.1 Global Pazopanib Annual Sales by Company (2020-2025)
  3.1.2 Global Pazopanib Sales Market Share by Company (2020-2025)
3.2 Global Pazopanib Annual Revenue by Company (2020-2025)
  3.2.1 Global Pazopanib Revenue by Company (2020-2025)
  3.2.2 Global Pazopanib Revenue Market Share by Company (2020-2025)
3.3 Global Pazopanib Sale Price by Company
3.4 Key Manufacturers Pazopanib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pazopanib Product Location Distribution
  3.4.2 Players Pazopanib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PAZOPANIB BY GEOGRAPHIC REGION

4.1 World Historic Pazopanib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Pazopanib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Pazopanib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pazopanib Market Size by Country/Region (2020-2025)
  4.2.1 Global Pazopanib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Pazopanib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pazopanib Sales Growth
4.4 APAC Pazopanib Sales Growth
4.5 Europe Pazopanib Sales Growth
4.6 Middle East & Africa Pazopanib Sales Growth

5 AMERICAS

5.1 Americas Pazopanib Sales by Country
  5.1.1 Americas Pazopanib Sales by Country (2020-2025)
  5.1.2 Americas Pazopanib Revenue by Country (2020-2025)
5.2 Americas Pazopanib Sales by Type (2020-2025)
5.3 Americas Pazopanib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pazopanib Sales by Region
  6.1.1 APAC Pazopanib Sales by Region (2020-2025)
  6.1.2 APAC Pazopanib Revenue by Region (2020-2025)
6.2 APAC Pazopanib Sales by Type (2020-2025)
6.3 APAC Pazopanib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pazopanib by Country
  7.1.1 Europe Pazopanib Sales by Country (2020-2025)
  7.1.2 Europe Pazopanib Revenue by Country (2020-2025)
7.2 Europe Pazopanib Sales by Type (2020-2025)
7.3 Europe Pazopanib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pazopanib by Country
  8.1.1 Middle East & Africa Pazopanib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Pazopanib Revenue by Country (2020-2025)
8.2 Middle East & Africa Pazopanib Sales by Type (2020-2025)
8.3 Middle East & Africa Pazopanib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pazopanib
10.3 Manufacturing Process Analysis of Pazopanib
10.4 Industry Chain Structure of Pazopanib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pazopanib Distributors
11.3 Pazopanib Customer

12 WORLD FORECAST REVIEW FOR PAZOPANIB BY GEOGRAPHIC REGION

12.1 Global Pazopanib Market Size Forecast by Region
  12.1.1 Global Pazopanib Forecast by Region (2026-2031)
  12.1.2 Global Pazopanib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pazopanib Forecast by Type (2026-2031)
12.7 Global Pazopanib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Pazopanib Product Portfolios and Specifications
  13.1.3 Novartis Pazopanib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Pazopanib Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Pazopanib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pazopanib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pazopanib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 200mgTables
Table 4. Major Players of 400mgTables
Table 5. Global Pazopanib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Pazopanib Sales Market Share by Type (2020-2025)
Table 7. Global Pazopanib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pazopanib Revenue Market Share by Type (2020-2025)
Table 9. Global Pazopanib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Pazopanib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Pazopanib Sale Market Share by Application (2020-2025)
Table 12. Global Pazopanib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pazopanib Revenue Market Share by Application (2020-2025)
Table 14. Global Pazopanib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Pazopanib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Pazopanib Sales Market Share by Company (2020-2025)
Table 17. Global Pazopanib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pazopanib Revenue Market Share by Company (2020-2025)
Table 19. Global Pazopanib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Pazopanib Producing Area Distribution and Sales Area
Table 21. Players Pazopanib Products Offered
Table 22. Pazopanib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pazopanib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Pazopanib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pazopanib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pazopanib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pazopanib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Pazopanib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pazopanib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pazopanib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pazopanib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Pazopanib Sales Market Share by Country (2020-2025)
Table 35. Americas Pazopanib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pazopanib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Pazopanib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Pazopanib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Pazopanib Sales Market Share by Region (2020-2025)
Table 40. APAC Pazopanib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pazopanib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Pazopanib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Pazopanib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Pazopanib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pazopanib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Pazopanib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Pazopanib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pazopanib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pazopanib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Pazopanib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Pazopanib
Table 52. Key Market Challenges & Risks of Pazopanib
Table 53. Key Industry Trends of Pazopanib
Table 54. Pazopanib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pazopanib Distributors List
Table 57. Pazopanib Customer List
Table 58. Global Pazopanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Pazopanib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pazopanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Pazopanib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pazopanib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Pazopanib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pazopanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Pazopanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pazopanib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Pazopanib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pazopanib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Pazopanib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pazopanib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Pazopanib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Novartis Basic Information, Pazopanib Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Pazopanib Product Portfolios and Specifications
Table 74. Novartis Pazopanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. GlaxoSmithKline Basic Information, Pazopanib Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Pazopanib Product Portfolios and Specifications
Table 79. GlaxoSmithKline Pazopanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pazopanib
Figure 2. Pazopanib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pazopanib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pazopanib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pazopanib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pazopanib Sales Market Share by Country/Region (2024)
Figure 10. Pazopanib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 200mgTables
Figure 12. Product Picture of 400mgTables
Figure 13. Global Pazopanib Sales Market Share by Type in 2025
Figure 14. Global Pazopanib Revenue Market Share by Type (2020-2025)
Figure 15. Pazopanib Consumed in Renal Cell Carcinoma
Figure 16. Global Pazopanib Market: Renal Cell Carcinoma (2020-2025) & (K Pcs)
Figure 17. Pazopanib Consumed in Soft Tissue Sarcoma
Figure 18. Global Pazopanib Market: Soft Tissue Sarcoma (2020-2025) & (K Pcs)
Figure 19. Pazopanib Consumed in Others
Figure 20. Global Pazopanib Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Pazopanib Sale Market Share by Application (2024)
Figure 22. Global Pazopanib Revenue Market Share by Application in 2025
Figure 23. Pazopanib Sales by Company in 2025 (K Pcs)
Figure 24. Global Pazopanib Sales Market Share by Company in 2025
Figure 25. Pazopanib Revenue by Company in 2025 ($ millions)
Figure 26. Global Pazopanib Revenue Market Share by Company in 2025
Figure 27. Global Pazopanib Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pazopanib Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pazopanib Sales 2020-2025 (K Pcs)
Figure 30. Americas Pazopanib Revenue 2020-2025 ($ millions)
Figure 31. APAC Pazopanib Sales 2020-2025 (K Pcs)
Figure 32. APAC Pazopanib Revenue 2020-2025 ($ millions)
Figure 33. Europe Pazopanib Sales 2020-2025 (K Pcs)
Figure 34. Europe Pazopanib Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pazopanib Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Pazopanib Revenue 2020-2025 ($ millions)
Figure 37. Americas Pazopanib Sales Market Share by Country in 2025
Figure 38. Americas Pazopanib Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pazopanib Sales Market Share by Type (2020-2025)
Figure 40. Americas Pazopanib Sales Market Share by Application (2020-2025)
Figure 41. United States Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pazopanib Sales Market Share by Region in 2025
Figure 46. APAC Pazopanib Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pazopanib Sales Market Share by Type (2020-2025)
Figure 48. APAC Pazopanib Sales Market Share by Application (2020-2025)
Figure 49. China Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pazopanib Sales Market Share by Country in 2025
Figure 57. Europe Pazopanib Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pazopanib Sales Market Share by Type (2020-2025)
Figure 59. Europe Pazopanib Sales Market Share by Application (2020-2025)
Figure 60. Germany Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pazopanib Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pazopanib Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pazopanib Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pazopanib Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pazopanib in 2025
Figure 74. Manufacturing Process Analysis of Pazopanib
Figure 75. Industry Chain Structure of Pazopanib
Figure 76. Channels of Distribution
Figure 77. Global Pazopanib Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pazopanib Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pazopanib Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pazopanib Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pazopanib Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pazopanib Revenue Market Share Forecast by Application (2026-2031)